Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Kirk Hansen to Antifibrinolytic Agents

This is a "connection" page, showing publications Kirk Hansen has written about Antifibrinolytic Agents.

 
Connection Strength
 
 
 
0.158
 
  1. Moore EE, Moore HB, Gonzalez E, Chapman MP, Hansen KC, Sauaia A, Silliman CC, Banerjee A. Postinjury fibrinolysis shutdown: Rationale for selective tranexamic acid. J Trauma Acute Care Surg. 2015 Jun; 78(6 Suppl 1):S65-9.
    View in: PubMed
    Score: 0.119
  2. Moore HB, Moore EE, Chapman MP, Hansen KC, Cohen MJ, Pieracci FM, Chandler J, Sauaia A. Does Tranexamic Acid Improve Clot Strength in Severely Injured Patients Who Have Elevated Fibrin Degradation Products and Low Fibrinolytic Activity, Measured by Thrombelastography? J Am Coll Surg. 2019 07; 229(1):92-101.
    View in: PubMed
    Score: 0.039
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)